Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice: 2024 Drug Supplement

Author: MiKaela Olsen, DNP, APRN-CNS, AOCNS®, FAAN, Kristine LeFebvre, DNP, RN, NPD-BC, AOCN®, Suzanne Walker, PhD, CRNP, BC, AOCN®, Elizabeth Dunphy, DNP, CRNP, BC, AOCN®
Affiliation:
Publisher: Oncology Nursing Society
Publication Date: 2025
ISBN 10: 1635930707
ISBN 13: 9781635930702
eISBN: 9781635930672
Edition: 2nd
Affiliation:
Publisher: Oncology Nursing Society
Publication Date: 2025
ISBN 10: 1635930707
ISBN 13: 9781635930702
eISBN: 9781635930672
Edition: 2nd
Description:
The newly released 2024 Drug Supplement, featuring more than 30 new U.S. Food and Drug Administration–approved antineoplastic medications from September 2021 through May 2024. The supplement provides the essential information needed to deliver safe, informed, and confident care to patients receiving these treatments. The information is organized in a user-friendly format for quick reference and is available in a digital format for easy access.
Related Titles